Outpatient drug purchases under the 340B discount program rose 22% to $53.7bn in 2022, according to new spending data released by the Health Resources and Services Administration. The upsurge continued a streak of 20%-plus annual increases in the program in recent years.
The spending figures were first released by Drug Channels Institute CEO Adam Fein on his Drug Channels blog after he...







